Latest news
Earnings Release: Here's Why Analysts Cut Their Pacific Biosciences of California, Inc. (NASDAQ:PACB) Price Target To US$2.29 - simplywall.stsimplywall.st · Sat, 08 Aug 2026 14:41:26 GMTFBRX Stock Alert: Halper Sadeh LLC is Investigating Whether Forte Biosciences, Inc. is Obtaining a Fair Price for its Shareholders - The AI JournalThe AI Journal · Sat, 08 Aug 2026 14:01:40 GMTThor Explorations, Strategic Minerals, London BTC, Genflow Biosciences, Pantheon International, Frontier IP - Small Cap Week in Review - Proactive financial newsProactive financial news · Sat, 08 Aug 2026 07:56:54 GMTPacific Biosciences of California (NASDAQ:PACB) Cut to "Sell" at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:32:14 GMTHow Stronger Q2 Results and New Equity Capacity Will Impact Neurocrine Biosciences (NBIX) Investors - simplywall.stsimplywall.st · Sat, 08 Aug 2026 06:26:14 GMTPacira BioSciences (NASDAQ:PCRX) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:17:05 GMTPulse Biosciences (NASDAQ:PLSE) Stock Rating Lowered by Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:05:06 GMTPrecision BioSciences (NASDAQ:DTIL) Lowered to "Sell" Rating by Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:48:57 GMT